Huidong Shi, PhD
Professor of Biochemistry and Molecular Biology, Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA, USA
Dr. Shi obtained his PhD in 1999 from Kyushu Institute of Technology, Japan and completed his post-doctoral training at University of Missouri-Columbia in 2003. Prior to moving to the Medical College of Georgia in 2009, he was an Assistant Professor at University of Missouri, Columbia, Missouri. Dr. Shi was named Georgia Cancer Coalition Distinguished Cancer Scholar in 2010.
Dr. Shi’s research interests are in the area of epigenomics, and most of his work focuses on developing high-throughput technologies for dissecting the complex epigenetic regulation in cancer and normal cells. His early research work includes the development of Expressed CpG Island Sequence Tags (ECISTs) microarray, and the Methylation Specific Oligonucleotide (MSO) microarray techniques for high-throughput DNA methylation analysis. Dr. Shi’s laboratory is currently utilizing next-generation sequencing platforms for genome-wide DNA methylation analysis in various cell types and tumor models. He is interested in understanding how DNA methylation and other epigenetic marks become disrupted and lead to common human diseases such as cancer, diabetes, cardiovascular disease, and immunological disorders.